# ST Elevation Myocardial Infarction trials: 128 new

Updated November 4, 2026.

128 clinical studies in ST Elevation Myocardial Infarction were first posted on ClinicalTrials.gov from November 26, 2024 to November 4, 2026; 14 have an industry sponsor and 104 are recruiting or about to. The newest, NCT07916701, was posted on November 4, 2026: Incremental Prognostic Utility of CBC-derived Inflammatory Indices After Incomplete Coronary... (Assiut University).

## The full list

New ST Elevation Myocardial Infarction clinical trials: 128 rows for $6.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 7 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/condition/st-elevation-myocardial-infarction

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 128
- Industry sponsored: 14
- Recruiting or not yet: 104
- Latest posted: November 4, 2026

## Newest trials

The newest 100 of 128, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07916701 | Incremental Prognostic Utility of CBC-derived Inflammatory Indices After Incomplete Coronary Revascularization: Association With 12-months... | Assiut University | Observational | Not yet recruiting | STEMI, High Risk NSTEMI | 440 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916701) |
| October 27, 2026 | NCT07898709 | Evaluating SGLT2 Inhibitors for the Reduction of No-Reflow Phenomenon in Patients Undergoing PCI | Al-Azhar University | Phase 2 | Not yet recruiting | No Reflow Phenomenon, Reperfusion Injuries, Myocardial, Myocardial Infarction, STEMI - ST Elevation Myocardial... | 100 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898709) |
| October 27, 2026 | NCT07898696 | Reducing Slow/No-Reflow With Prophylactic High-Dose Intracoronary Adenosine Protocol in ST-Elevation Myocardial Infarction The REFLOW AMI... | Prof Muzaffar Ali Zahidi | Not applicable | Recruiting | ST-Elevation Myocardial Infarction (STEMI) | 660 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07898696) |
| October 22, 2026 | NCT07890168 | Integrated Assessment of Immune-Inflammatory and Metabolic Biomarkers for Prediction of Coronary No-Reflow Following Primary PCI in STEMI... | Sohag University | Observational | Recruiting | Integrated Assessment, Immune-Inflammatory, Metabolic Biomarkers, Coronary No-Reflow, Primary Percutaneous Coronary... | 400 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890168) |
| October 20, 2026 | NCT07882849 | AI-ECG Detection of Occlusion Myocardial Infarction at Emergency Department Triage (TRIACS) | University Medical Centre Maribor | Observational | Not yet recruiting | Acute Coronary Syndromes, Chest Pain, Myocardial Infarction (MI), NSTEMI - Non-ST Segment Elevation MI, ST Elevation... | 1,000 | Slovenia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07882849) |
| October 15, 2026 | NCT07876791 | Multimodality Assessment of Myocardial Reperfusion After Primary Percutaneous Coronary Intervention | Assiut University | Observational | Not yet recruiting | ST Elevation (STEMI) Myocardial Infarction, Microvascular Obstruction (MVO) | 90 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07876791) |
| October 15, 2026 | NCT07875179 | IMPROVE-STEMI: pPCI Plus Low-dose r-SK in STEMI | The Affiliated Hospital of Xuzhou Medical University | Phase 4 | Not yet recruiting | ST Elevation Myocardial Infarction (STEMI) | 3,300 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875179) |
| October 8, 2026 | NCT07866144 | Prediction of Adverse Events From Non-PCI Coronary Plaques Using Machine Learning | A.O.U. Città della Salute e della Scienza | Observational | Completed | STEMI, NSTEMI, Chronic Coranary Sindrome, Unstable Angina (UA) | 600 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07866144) |
| October 6, 2026 | NCT07860086 | On vs Off-hour PPCI in STEMI Patients | Assiut University | Observational | Not yet recruiting | Acute STEMI, PPCI, Observational Study, Coronary Artery Disease (CAD) | 450 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07860086) |
| September 22, 2026 | NCT07835282 | Germany on Target Registry | Deutsche Gesellschaft für Lipidologie e. V. (DGFL) - Lipid-Liga | Observational | Not yet recruiting | Myocardial Infarction (MI), Dyslipidemias | 10,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835282) |
| September 17, 2026 | NCT07826572 | Beyond the Mehran Risk Score: Predictive Value of Total Ischemic Time for Contrast-Induced Nephropathy in ST Segment Elevation Myocardial... | Assiut University | Observational | Not yet recruiting | ST Elevation (STEMI) Myocardial Infarction, Contrast Induced Nephropathy (CIN), Acute Kidney Injury | 400 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07826572) |
| September 17, 2026 | NCT07824323 | Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome | Taipei Medical University Hospital | Phase 4 | Recruiting | Acute Coronary Syndromes, Dyslipidemia | 400 | Taiwan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824323) |
| September 17, 2026 | NCT07824050 | Analysis of Life-threatening ARrhythMias After Acute Coronary Syndrome | Catharina Ziekenhuis Eindhoven | Observational | Recruiting | Acute Coronary Syndromes (ACS), Ventricular Tachycardia (VT), Ventricular Fibrillation, Pulseless Electrical Activity... | 2,775 | Netherlands | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824050) |
| September 14, 2026 | NCT07817472 | Optimal Timing of Microaxial Flow Pump(Impella CP) in AMI-related Cardiogenic Shock | Chonnam National University Hospital | Not applicable | Not yet recruiting | Myocardial Infarction (MI), Cardiogenic Shock, ST-Segment Elevation Myocardial Infarction(STEMI), Non-ST-Segment... | 126 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817472) |
| September 9, 2026 | NCT07810686 | Smartphone AI Assistance for Prehospital ECG Interpretation | École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care | Not applicable | Recruiting | Acute Coronary Syndromes, ST Elevation Myocardial Infarction, Non-ST Elevated Myocardial Infarction, Myocardial... | 144 | Switzerland | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07810686) |
| September 8, 2026 | NCT07806370 | A Single-Center, Retrospective, Propensity-Score-Matched Cohort Study Comparing Drug-Coated Balloon Versus Drug-Eluting Stent for Reducing... | Xijing Hospital | Observational | Recruiting | ST Elevation Myocardial Infarction (STEMI), Acute Coronary Syndromes (ACS) | 668 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07806370) |
| August 24, 2026 | NCT07780942 | SMARTwatch for the Diagnosis of ST-segment Elevation Myocardial Infarction in Patients With Chest Pain | Hospital General Universitario Santa Lucia | Observational | Recruiting | STEMI - ST-segment Elevation Myocardial Infarction, Chest Pain | 100 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780942) |
| August 21, 2026 | NCT07780552 | CHIP in Health and Disease | VASCage GmbH | Observational | Not yet recruiting | Clonal Hematopoiesis, Clonal Hematopoiesis of Indeterminate Potential, Clonal Cytopenia of Undetermined Significance... | 120 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07780552) |
| August 20, 2026 | NCT07776288 | Combined Antioxidant Therapy for Acute Myocardial Infarction | University of Chile | Phase 2 | Not yet recruiting | Acute Myocardial Infarction (AMI), ST Elevation (STEMI) Myocardial Infarction, Reperfusion Injuries, Myocardial | 46 | Chile | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07776288) |
| August 12, 2026 | NCT07761455 | Prophylactic IABP in Delayed-Presentation Anterior STEMI | Qilu Hospital of Shandong University | Not applicable | Not yet recruiting | Acute Anterior ST-Segment Elevation Myocardial Infarction | 504 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761455) |
| August 6, 2026 | NCT07749014 | Timing of Empagliflozin in Primary PCI: Pre-Reperfusion Versus Post-Reperfusion Versus Placebo in South Asian STEMI Patients | Rehman Medical Institute - RMI | Phase 2 | Not yet recruiting | ST-elevation Myocardial Infarction (STEMI), Acute Myocardial Infarction (AMI), Coronary Artery Disease | 480 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07749014) |
| July 15, 2026 | NCT07706335 | Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients. | Assiut University | Observational | Not yet recruiting | STEMI, No-Reflow Phenomenon, Diabetic Patient | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07706335) |
| July 8, 2026 | NCT07689591 | Noninvasive Artificial Venous Stasis for Reperfusion in STEMI | Firat University | Observational | Recruiting | STEMI - ST Elevation Myocardial Infarction | 500 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07689591) |
| July 7, 2026 | NCT07687576 | Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction... | Oxford University Hospitals NHS Trust | Phase 2/3 | Recruiting | STEMI - ST Elevation Myocardial Infarction | 60 | United Kingdom | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07687576) |
| July 6, 2026 | NCT07684742 | Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome | Gyeongsang National University Hospital | Phase 4 | Recruiting | Acute Coronary Syndromes, STEMI, NSTEMI, Unstable Angina | 2,200 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684742) |
| June 15, 2026 | NCT07646977 | CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial) | Odense University Hospital | Not applicable | Recruiting | ST Elevation Myocardial Infarction, Coronary Microvascular Dysfunction, Percutaneous Coronary Intervention | 100 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646977) |
| June 11, 2026 | NCT07641231 | Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | Phase 4 | Not yet recruiting | STEMI - ST Elevation Myocardial Infarction | 240 | Russia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07641231) |
| June 4, 2026 | NCT07625306 | Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARL | Novartis Pharmaceuticals | Phase 3 | Withdrawn | Acute Coronary Syndrome (ACS) | 0 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07625306) |
| June 2, 2026 | NCT07621107 | Effect of Guanxinning Tablet on Coronary Microcirculation After Primary Percutaneous Coronary Intervention in Patients With Acute... | Beijing Anzhen Hospital | Phase 2 | Not yet recruiting | STEMI (ST Elevation MI), STEMI - ST Elevation Myocardial Infarction, STEMI, CMD, Coronary Microvascular Dysfunction... | 70 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621107) |
| May 29, 2026 | NCT07616024 | Intravascular Ultrasound guidaNce versuS angIoGrapHy Guidance in Patients With ST-segment Elevation Myocardial Infarction | Shanghai Zhongshan Hospital | Not applicable | Not yet recruiting | STEMI, PCI | 2,488 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07616024) |
| May 29, 2026 | NCT07615023 | Clonal Hematopoiesis of Indeterminate Potential and Infarct Severity in ST-Elevation Myocardial Infarction | Medical University Innsbruck | Observational | Recruiting | ST-elevation Myocardial Infarction (STEMI), Clonal Hematopoiesis of Indeterminate Potential (CHIP) | 350 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07615023) |
| May 22, 2026 | NCT07601997 | Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study) | Myomed Technology (Shaoxing) Co., Ltd. | Not applicable | Not yet recruiting | STEMI - ST Elevation Myocardial Infarction | 20 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07601997) |
| May 20, 2026 | NCT07598565 | The CORE - μFR Clinical Trial | University of Roma La Sapienza | Not applicable | Not yet recruiting | Acute Coronary Syndromes (ACS), NSTEMI - Non-ST-Segment Elevation Myocardial Infarction, STEMI - ST Elevation... | 350 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07598565) |
| May 14, 2026 | NCT07587294 | Efficacy and Safety of Ultrasound Modulation of Stellate Ganglion for the Prevention of Ventricular Arrhythmia in Patients With ST-segment... | Renmin Hospital of Wuhan University | Not applicable | Recruiting | Acute ST-segment Elevation Myocardial Infarction (Patients Undergoing Emergency PCI) | 100 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07587294) |
| May 14, 2026 | NCT07586865 | Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction | Beijing Northland Biotech. Co., Ltd. | Phase 2 | Not yet recruiting | Acute Myocardial Infarction (AMI), Acute Myocardial Infarction of Anterior Wall, Acute Myocardial Infarction With ST... | 189 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07586865) |
| May 13, 2026 | NCT07583784 | Abbreviated Antithrombotic Therapy After PCI in Patients With AF and AMI | Chonnam National University Hospital | Not applicable | Recruiting | Myocardial Infarction (MI), ST-Segment Elevation Myocardial Infarction(STEMI), NSTEMI - Non-ST-Segment Elevation... | 860 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07583784) |
| May 5, 2026 | NCT07567625 | Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV) | Harbin Medical University | Not applicable | Recruiting | Acute Myocardial Infarction (AMI), ST-Segment Elevation Myocardial Infarction(STEMI), Non-ST-Segment Elevation... | 2,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07567625) |
| April 27, 2026 | NCT07551700 | Efficacy of Thrombus Aspiration in Patients With Acute ST-Segment Elevation Myocardial Infarction: A Prospective, Multicenter, Randomized... | First Affiliated Hospital Xi'an Jiaotong University | Not applicable | Not yet recruiting | ST-segment Elevation Myocardial Infarction (STEMI) | 6,760 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07551700) |
| April 17, 2026 | NCT07536802 | Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention | National Institute of Cardiovascular Diseases, Pakistan | Phase 4 | Recruiting | ST-Segment Elevation Myocardial Infarction (STEMI), No-Reflow Phenomenon, Coronary Slow Flow, Acute Myocardial... | 1,148 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07536802) |
| April 9, 2026 | NCT07519590 | One-Time Complete Revascularization Versus Staged PCI in MVD During Pharmaco-Invasive STEMI Strategy | Tanta University | Not applicable | Completed | Myocardial Infarction, Coronary Artery Disease | 112 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07519590) |
| April 8, 2026 | NCT07517523 | Ventricular Arrhythmias in Acute Myocardial Infarction | Poitiers University Hospital | Observational | Recruiting | Ventricular Arrhythmia, Acute Myocardial Infarction (AMI) | 500 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07517523) |
| April 6, 2026 | NCT07511257 | Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia | Instituto Nacional de Cardiologia Ignacio Chavez | Phase 4 | Recruiting | Coronary Artery Ectasia, Acute Coronary Syndromes (ACS), STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST... | 326 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07511257) |
| March 31, 2026 | NCT07502521 | Dexrazoxane to Protect Against Hemorrhagic STEMI | Rohan Dharmakumar | Phase 2 | Completed | Acute Myocardial Infarction (AMI) | 50 | India | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07502521) |
| March 17, 2026 | NCT07478003 | Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial | Thomas Engstrom | Phase 3 | Recruiting | STEMI - ST Elevation Myocardial Infarction | 5,204 | Denmark | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07478003) |
| March 17, 2026 | NCT07477405 | Drug-coatEd Balloon Multicentric Registry in Spain and PORTugal | Portuguese Association of Interventional Cardiology | Observational | Not yet recruiting | Coronary Artery Disease (CAD), ST-elevation Myocardial Infarction (STEMI) | 1,200 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07477405) |
| March 4, 2026 | NCT07449429 | AI-Assisted Coronary Syndrome Subtyping From Admission History of Present Illness: A Clinician Reader Study | China National Center for Cardiovascular Diseases | Observational | Completed | Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)), Acute... | 10 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07449429) |
| March 3, 2026 | NCT07445737 | Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction | Assistance Publique - Hôpitaux de Paris | Phase 3 | Not yet recruiting | STEMI - ST Elevation Myocardial Infarction | 700 | France | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07445737) |
| March 3, 2026 | NCT07444957 | Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease | Fundación Interhospitalaria para la Investigación Cardiovascular FIC | Observational | Recruiting | Coronary Arterial Disease (CAD), NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Stable Angina, Unstable... | 1,118 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07444957) |
| February 27, 2026 | NCT07436429 | Drug-Coated Balloon Primary PCI in ST-Segment Elevation Myocardial Infarction | Medical University of Vienna | Observational | Recruiting | Myocardial Infarction (MI), ST-Elevation Myocardial Infarction, STEMI, STEMI (STE-ACS), Acute Coronary Syndrome (ACS)... | 300 | Austria | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07436429) |
| February 23, 2026 | NCT07427199 | Effect of Digitally Supported Medical Nutrition Therapy on Left Ventricular Ejection Fraction in Patients With ST-Elevation Myocardial... | Saglik Bilimleri Universitesi | Not applicable | Recruiting | ST-elevation Myocardial Infarction (STEMI) | 200 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07427199) |
| February 13, 2026 | NCT07409441 | Korea Acute Myocardial Infarction Registry | Samsung Medical Center | Observational | Not yet recruiting | Myocardial Infarction, Acute | 20,000 | South Korea | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07409441) |
| February 2, 2026 | NCT07380919 | Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial... | Federico II University | Phase 2/3 | Recruiting | STEMI (ST Elevation MI) | 100 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07380919) |
| February 2, 2026 | NCT07380659 | Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 1 | Not yet recruiting | Cardiogenic Shock, Cardiogenic Shock Post Myocardial Infarction, STEMI - ST Elevation Myocardial Infarction | 18 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07380659) |
| January 27, 2026 | NCT07369037 | Association of Prognostic Nutritional Index and Controlling Nutritional Status Score With ST Elevation Myocardial Infarction | Muğla Sıtkı Koçman University | Observational | Completed | CONUT Score, ST Elevation (STEMI) Myocardial Infarction, Mortality | 1,000 | Turkey (Türkiye) | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07369037) |
| January 26, 2026 | NCT07366684 | Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome | Clinical Center Niš | Observational | Recruiting | ST Elevation (STEMI) Myocardial Infarction, Non ST Elevation Myocardial Infarction (NSTEMI), Unstable Angina Pectoris | 550 | Serbia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07366684) |
| January 23, 2026 | NCT07362446 | Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction | Nyrada Pty Ltd | Phase 2 | Recruiting | Myocardial Infarction, Reperfusion Injury, AMI, STEMI (ST Elevation MI) | 300 | Australia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07362446) |
| January 23, 2026 | NCT07361783 | Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 Trial | Chen Jing | Not applicable | Recruiting | Primary PCI, ST-elevation Myocardial Infarction (STEMI) | 6,294 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07361783) |
| January 21, 2026 | NCT07354035 | The Coronary Sinus Balloon Pump in STEMI | Shanghai MicroPort Rhythm MedTech Co., Ltd. | Not applicable | Not yet recruiting | STEMI | 177 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354035) |
| January 8, 2026 | NCT07325955 | Effect of Long Term Trimetazidine Treatment on Final Myocardial Fibrosis for ST Eleviation Myocardial Infarction | Chinese PLA General Hospital | Observational | Completed | ST Elevation Myocardial Infarction (STEMI) | 194 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07325955) |
| January 7, 2026 | NCT07323238 | Hong Kong Cardiogenic Shock Initiative | Prince of Wales Hospital, Shatin, Hong Kong | Observational | Not yet recruiting | Cardiogenic Shock Acute, STEMI - ST Elevation Myocardial Infarction, Cardiogenic Shock, Cardiogenic Shock Post... | 320 | Hong Kong | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07323238) |
| December 29, 2025 | NCT07306182 | A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction | Beijing Sungen Biomedical Technology Co., Ltd | Phase 2 | Recruiting | Acute Anterior ST-Segment Elevation Myocardial Infarction | 210 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07306182) |
| December 22, 2025 | NCT07297589 | Epicardial Cardiac Fat-CT (EPIC-CT) | Instituto Mexicano del Seguro Social | Phase 3 | Recruiting | STEMI - ST Elevation Myocardial Infarction, Epicardial Fat | 136 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07297589) |
| December 19, 2025 | NCT07295223 | Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial) | Instituto Mexicano del Seguro Social | Phase 3 | Completed | Acute Myocardial Infarction With ST Elevation | 44 | Mexico | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07295223) |
| December 19, 2025 | NCT07294911 | Predictors of Contrast-induced Acute Renal Injury in Patients With Acute Coronary Syndrome | Karaganda Medical University | Observational | Completed | Acute Coronary Syndrome, Contrast-Induced Acute Kidney Injury | 88 | Kazakhstan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07294911) |
| December 19, 2025 | NCT07293832 | Impact of Cardio-Selective Beta-Blockers on Infarct Size After Acute Myocardial Infarction | Aristotle University Of Thessaloniki | Observational | Recruiting | STEMI | 100 | Greece | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07293832) |
| December 18, 2025 | NCT07291999 | Tissue Characterization in STEMI Using Cardiac MRI: a Multicenter Registry | Fundación para la Investigación del Hospital Clínico de Valencia | Observational | Active not recruiting | Ischemic Cardiovascular Disease, Magnetic Resonance | 500 | Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07291999) |
| December 18, 2025 | NCT07290699 | Intensive Cholesterol-Lowering Within 24 Hours of PCI Perioperative Period | Second Affiliated Hospital of Nanchang University | Phase 4 | Not yet recruiting | STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI) | 2,442 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07290699) |
| December 16, 2025 | NCT07283809 | European Unified Registries for Heart Care Evaluation and Randomised Trials Italy | Heart Care Foundation | Observational | Recruiting | ACS - Acute Coronary Syndrome | 5,000 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07283809) |
| December 11, 2025 | NCT07277400 | Development and Validation of a Cardiac Magnetic Resonance-Based Multimodal Deep Learning Model for Long-Term Outcome Prediction in... | Qian geng | Observational | Not yet recruiting | ST Elevation (STEMI) Myocardial Infarction | 800 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07277400) |
| December 4, 2025 | NCT07264881 | For Patients With Myocardial Infarction and Multiple Vessel: Testing if Ultrasound (UFR) Can Guide All Needed Treatment in One Procedure... | Beijing Anzhen Hospital | Observational | Not yet recruiting | Microvascular Obstruction (MVO), Multivessel Coronary Artery Disease, ACS (Acute Coronary Syndrome), ST Elevation... | 200 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07264881) |
| December 4, 2025 | NCT07263282 | LA Strain in Predicting Early Complication in STEMI After PPCI | Assiut University | Observational | Not yet recruiting | ST Elevation (STEMI) Myocardial Infarction | 135 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07263282) |
| December 3, 2025 | NCT07261514 | Correlation Between Triglyceride Glucose Index and Myocardial Injury Assessed by Cardiac Magnetic Resonance Imaging (CMR) in Patients With... | Chinese PLA General Hospital | Observational | Completed | ST Elevation (STEMI) Myocardial Infarction | 674 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07261514) |
| December 2, 2025 | NCT07257198 | Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone | Montreal Heart Institute | Phase 3 | Recruiting | NSTEMI - Non-ST Segment Elevation MI, STEMI (ST Elevation MI), Myocardial Infarction | 2,570 | Canada | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07257198) |
| November 14, 2025 | NCT07229248 | DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial | National Institute of Cardiovascular Diseases, Pakistan | Phase 3 | Recruiting | STEMI (ST Elevation MI) | 496 | Pakistan | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07229248) |
| September 29, 2025 | NCT07195812 | Rivaroxaban for Slow Coronary Flow After PCI in STEMI | Second Affiliated Hospital, Zhejiang University, School of Medicine | Phase 4 | Not yet recruiting | ST Elevation Myocardial Infarction, No-Reflow Phenomenon | 60 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07195812) |
| September 16, 2025 | NCT07176104 | Functional Milk Supplementation to Reduce In-Stent Restenosis in STEMI Patients (SMASOEA Trial) | Raffaele Marfella | Not applicable | Not yet recruiting | ST-elevation Myocardial Infarction (STEMI), In-stent Restenosis | 140 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07176104) |
| September 16, 2025 | NCT07175259 | Relation of Total Ischemic Time to Repolarization Indices and Their Impact on Outcomes Among STEMI Patients Undergoing Primary PCI | Assiut University | Observational | Not yet recruiting | ST Elevation (STEMI) Myocardial Infarction of Other Sites, Repolarization Indices, Total Ischemic Time, Primary... | 500 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07175259) |
| September 8, 2025 | NCT07160491 | Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI | Shenyang Northern Hospital | Not applicable | Recruiting | STEMI - ST Elevation Myocardial Infarction | 3,356 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07160491) |
| September 4, 2025 | NCT07155395 | Inflammatory and Hematological Indices in Diabetic STEMI Patients Undergoing Primary PCI | Assiut University | Observational | Not yet recruiting | STEMI, Diabete Mellitus | 1,000 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07155395) |
| September 2, 2025 | NCT07149961 | Curcumin-Piperine Supplementation in STEMI - SPICE STEMI Trial | Universitas Diponegoro | Not applicable | Completed | ST Elevation Myocardial Infarction (STEMI), Malondialdehyde, Hs-CRP, Curcumin, Curcuma Xanthorrhiza, High-sensitivity... | 50 | Indonesia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07149961) |
| August 27, 2025 | NCT07144059 | Impact of Non-medicalized ECG Practices Initiated by SAMU in Dispatch Strategies | Centre Hospitalier Sud Francilien | Observational | Not yet recruiting | Acute Coronary Syndromes | 350 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07144059) |
| August 24, 2025 | NCT07139860 | Artificial Intelligence System for Early Warning of Adverse Events in Acute Myocardial Infarction | Hui Chen | Observational | Recruiting | Acute Myocardial Infarction With ST Elevation, Intelligent Management Platform, Early Warning | 1,400 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07139860) |
| August 19, 2025 | NCT07129850 | Bempedoic Acid in PPCI Impact on Clinical Outcome and Inflammatory Markers | Assiut University | Observational | Not yet recruiting | ST Elevation (STEMI) Myocardial Infarction | 100 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07129850) |
| August 11, 2025 | NCT07114978 | Prognostic Value of the LVOT VTI in STEMI Patients Undergoing PPCI | Assiut University | Observational | Not yet recruiting | LVOT VTI, STEMI - ST Elevation Myocardial Infarction (MI), Primary Percutaneous Coronary Intervention | 125 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07114978) |
| August 4, 2025 | NCT07102628 | Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes | Novartis Pharmaceuticals | Phase 3 | Recruiting | Acute Coronary Syndrome | 300 | Argentina, Australia, Canada, China, France, Germany, Hong Kong, Hungary... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07102628) |
| July 24, 2025 | NCT07082153 | The First-In-Man Use of Coronary Sinus Balloon Pump in STEMI Patients Treated by Primary PCI | Shanghai MicroPort Rhythm MedTech Co., Ltd. | Not applicable | Not yet recruiting | STEMI | 10 |  | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07082153) |
| July 18, 2025 | NCT07072858 | Using Cardiac MRI to Predict Outcomes in Patients With STEMI | Chinese PLA General Hospital | Observational | Recruiting | Myocardial Infarction (MI), ST Segment Elevation Myocardial Infarction (STEMI), Magnetic Resonance Imaging (MRI), Heart... | 1,000 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07072858) |
| July 10, 2025 | NCT07058857 | The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocardial Infarction - A... | Universitas Diponegoro | Not applicable | Recruiting | ST Elevation Myocardial Infarction | 100 | Indonesia | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07058857) |
| July 9, 2025 | NCT07057492 | A Prospective Multicenter Clinical Study on the Long-term Prognosis of Patients With ST-segment Elevation Myocardial Infarction Using... | Chinese PLA General Hospital | Observational | Completed | ST-segment Elevation Myocardial Infarction (STEMI) | 800 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07057492) |
| July 8, 2025 | NCT07055152 | Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients | University of Pisa | Observational | Recruiting | MINOCA, STEMI, Normal | 90 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07055152) |
| June 27, 2025 | NCT07041840 | ReModeling in ST-elevation myocARrdial Infarction: a Comparison of Left VEntricuLar Functions in Long-term Follow-up Among STEMI Patients | University of Pisa | Observational | Recruiting | STEMI | 80 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07041840) |
| June 18, 2025 | NCT07026708 | TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary... | University Hospital Centre Mother Teresa | Observational | Recruiting | ACS (Acute Coronary Syndrome), Myocardial Infarction (MI), Myocardial Inflammation, Inflammation Biomarkers, NSTEMI... | 1,600 | Albania | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07026708) |
| May 13, 2025 | NCT06967194 | Early Beta Blocker Administration in STEMI Patients With SCAI B Status | Tel-Aviv Sourasky Medical Center | Not applicable | Recruiting | ST Segment Elevation Myocardial Infarction (STEMI), Cardiogenic Shock Post Myocardial Infarction | 200 | Israel | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06967194) |
| May 13, 2025 | NCT06966674 | No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track | Kafrelsheikh University | Not applicable | Recruiting | No-Reflow, STEMI, Intracoronary, Tirofiban | 60 | Egypt | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06966674) |
| May 11, 2025 | NCT06965023 | Microplastics and Nanoplastics (MNPs) in Patients With ST-elevation Myocardial Infarction (STEMI) | Azienda Ospedaliera "Sant'Andrea" | Observational | Recruiting | ST-elevation Myocardial Infarction (STEMI), Microplastics, Nanoplastics, Pollution Exposure | 130 | Italy | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06965023) |
| May 4, 2025 | NCT06956560 | Platelet Derived Growth Factor Receptor ß (PDGFRß) Imaging in Cardiac Fibrosis | Uppsala University | Observational | Recruiting | ST-Elevation Myocardial Infarction (STEMI), Heart Failure With Preserved Ejection Fraction (HFpEF) | 30 | Sweden | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06956560) |
| April 30, 2025 | NCT06951724 | Coronary Aspiration Catheter Clinical Trial | BrosMed Medical Co., Ltd | Not applicable | Recruiting | ST-segment Elevation Myocardial Infarction (STEMI) | 144 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06951724) |
| April 27, 2025 | NCT06947564 | AccuIMR Predicts Microvascular Obstruction and Infarct Size in STEMI Patients | RenJi Hospital | Observational | Completed | Coronary Artery Disease, STEMI - ST Elevation Myocardial Infarction, Microvascular Coronary Artery Disease | 843 | China | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06947564) |
| April 27, 2025 | NCT06945900 | Emergency Medical Services (EMS) Telehealth to Speed STEMI Reperfusion | Wake Forest University Health Sciences | Observational | Completed | STEMI - ST Elevation Myocardial Infarction | 11 | United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06945900) |
| April 23, 2025 | NCT06939738 | Artificial Intelligence Scalable Solution for ST Myocardial Infarction | Idoven 1903 S.L. | Observational | Completed | Acute Myocardial Infarction (AMI) | 489 | Portugal, Spain | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06939738) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Assiut University | 12 | November 4, 2026 |
| Chinese PLA General Hospital | 5 | January 8, 2026 |
| Beijing Anzhen Hospital | 4 | June 2, 2026 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 3 | February 2, 2026 |
| Chonnam National University Hospital | 2 | September 14, 2026 |
| Novartis Pharmaceuticals | 2 | June 4, 2026 |
| Medical University Innsbruck | 2 | May 29, 2026 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 | April 27, 2026 |
| National Institute of Cardiovascular Diseases, Pakistan | 2 | April 17, 2026 |
| Rohan Dharmakumar | 2 | March 31, 2026 |
| China National Center for Cardiovascular Diseases | 2 | March 4, 2026 |
| Shanghai MicroPort Rhythm MedTech Co., Ltd. | 2 | January 21, 2026 |
| Instituto Mexicano del Seguro Social | 2 | December 22, 2025 |
| Universitas Diponegoro | 2 | September 2, 2025 |
| University of Pisa | 2 | July 8, 2025 |
| CorFlow Therapeutics AG | 2 | April 20, 2025 |
| Al-Azhar University | 1 | October 27, 2026 |
| Prof Muzaffar Ali Zahidi | 1 | October 27, 2026 |
| Sohag University | 1 | October 22, 2026 |
| University Medical Centre Maribor | 1 | October 20, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 59 | November 4, 2026 |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 34 | October 27, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 11 | October 27, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 11 | October 15, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 10 | June 4, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 2 | July 7, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 1 | February 2, 2026 |

## By country

| Country | New trials | Latest |
| --- | --- | --- |
| [China](https://specstream.ai/data/clinical-trials/country/china) | 28 | October 15, 2026 |
| [Italy](https://specstream.ai/data/clinical-trials/country/italy) | 10 | October 8, 2026 |
| [Egypt](https://specstream.ai/data/clinical-trials/country/egypt) | 8 | October 27, 2026 |
| [Pakistan](https://specstream.ai/data/clinical-trials/country/pakistan) | 5 | October 27, 2026 |
| [South Korea](https://specstream.ai/data/clinical-trials/country/south-korea) | 5 | September 14, 2026 |
| [Spain](https://specstream.ai/data/clinical-trials/country/spain) | 5 | August 24, 2026 |
| [Austria](https://specstream.ai/data/clinical-trials/country/austria) | 4 | August 21, 2026 |
| [Indonesia](https://specstream.ai/data/clinical-trials/country/indonesia) | 4 | September 2, 2025 |
| [United States](https://specstream.ai/data/clinical-trials/country/united-states) | 4 | April 27, 2025 |
| [Switzerland](https://specstream.ai/data/clinical-trials/country/switzerland) | 3 | September 9, 2026 |
| [Turkey (Türkiye)](https://specstream.ai/data/clinical-trials/country/turkey-t-rkiye) | 3 | July 8, 2026 |
| [France](https://specstream.ai/data/clinical-trials/country/france) | 3 | April 8, 2026 |
| [Mexico](https://specstream.ai/data/clinical-trials/country/mexico) | 3 | April 6, 2026 |
| [India](https://specstream.ai/data/clinical-trials/country/india) | 3 | March 31, 2026 |
| [Germany](https://specstream.ai/data/clinical-trials/country/germany) | 3 | August 4, 2025 |
| [Denmark](https://specstream.ai/data/clinical-trials/country/denmark) | 2 | June 15, 2026 |
| [Serbia](https://specstream.ai/data/clinical-trials/country/serbia) | 2 | January 26, 2026 |
| [Australia](https://specstream.ai/data/clinical-trials/country/australia) | 2 | January 23, 2026 |
| [Hong Kong](https://specstream.ai/data/clinical-trials/country/hong-kong) | 2 | January 7, 2026 |
| [Canada](https://specstream.ai/data/clinical-trials/country/canada) | 2 | December 2, 2025 |
| [Israel](https://specstream.ai/data/clinical-trials/country/israel) | 2 | May 13, 2025 |
| [Slovenia](https://specstream.ai/data/clinical-trials/country/slovenia) | 1 | October 20, 2026 |
| [Taiwan](https://specstream.ai/data/clinical-trials/country/taiwan) | 1 | September 17, 2026 |
| [Netherlands](https://specstream.ai/data/clinical-trials/country/netherlands) | 1 | September 17, 2026 |
| [Chile](https://specstream.ai/data/clinical-trials/country/chile) | 1 | August 20, 2026 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).